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Endocannabinoids are well established as in-
hibitors of chemical synaptic transmission via
presynaptic activation of the cannabinoid type
1 receptor (CB1R). Contrasting this notion, we
show that dendritic release of endocannabi-
noids mediates potentiation of synaptic trans-
mission at mixed (electrical and chemical)
synaptic contacts on the goldfish Mauthner
cell. Remarkably, the observed enhancement
was not restricted to the glutamatergic compo-
nent of the synaptic response but also included
a parallel increase in electrical transmission.
This effect involved the activation of CB1 recep-
tors and was indirectly mediated via the release
of dopamine from nearby varicosities, which in
turn led to potentiation of the synaptic response
via a cAMP-dependent protein kinase-medi-
ated postsynaptic mechanism. Thus, endocan-
nabinoid release can potentiate synaptic trans-
mission, and its functional roles include the
regulation of gap junction-mediated electrical
synapses. Similar interactions between endo-
cannabinoid and dopaminergic systems may
be widespread and potentially relevant for the
motor and rewarding effects of cannabis deriv-
atives.
INTRODUCTION
Endocannabinoids, diffusible retrograde lipidic messen-
gers, regulate the strength of chemical synapses (re-
viewed in Chevaleyre et al., 2006). The central actions of
both endogenous (typically anandamide and 2-arachido-
noyl-glycerol) and exogenous (i.e., derivatives of mari-
juana products) cannabinoids are generally mediated by
activation of the cannabinoid type 1 receptor (CB1R)
(Freund et al., 2003). This receptor constitutes one of the
most abundant G protein-coupled receptors in the
mammalian brain and, although widespread, is heavily1034 Neuron 56, 1034–1047, December 20, 2007 ª2007 Elseviexpressed in basal ganglia and prefrontal cortices, where
dopamine regulation is believed to be essential for both
motor control and reward mechanisms (Van der Stelt
and Di Marzo, 2003). Regardless of the nature of the
synapse (excitatory or inhibitory), the involved brain struc-
ture, or the duration of the effect (short or long term), endo-
cannabinoids have been mostly reported to promote
depression of synaptic transmission via a presynaptic
mechanism (Kreitzer and Regehr, 2001; Ohno-Shosaku
et al., 2001; Wilson and Nicoll, 2001; Gerdeman et al.,
2002; Robbe et al., 2002; Alger, 2002; Brown et al.,
2003; Chevaleyre et al., 2006). Thus, release of endocan-
nabinoids and/or activation of CB1Rs are expected to trig-
ger synaptic depression, suggesting a general role in
downregulating chemical synaptic transmission within
neural circuits across the nervous system.
In contrast, no effects of the CB1 signaling system on
gap junction-mediated electrical synapses have been re-
ported. Because of their accessibility to in vivo experi-
mentation, identifiable auditory afferents terminating as
mixed synaptic contacts on the lateral dendrite of the
goldfish Mauthner (M) cell known as Large Myelinated
Club endings (‘‘Club endings’’) constitute a valuable
model for the study of basic mechanisms of electrical
and chemical transmission in vertebrates (reviewed in
Pereda et al., 2004). The M cells are a pair of unusually
large reticulospinal neurons located in the medulla of tel-
eosts and are essential for the organization of sensory-
evoked escape responses (Korn and Faber, 2005). While
excitatory chemical transmission at Club endings is me-
diated by glutamate (Wolszon et al., 1997), electrical
transmission is mediated via homotypic connexin 35
(Cx35) gap junction channels (Pereda et al., 2003), the
fish ortholog of the widespread mammalian neuronal
connexin 36 (Cx36) (O’Brien et al., 1998; Condorelli
et al., 1998). Remarkably, synapses at these terminals
are highly modifiable and undergo activity-dependent
potentiation of both the electrical and chemical compo-
nents of their postsynaptic response (Yang et al., 1990;
Pereda and Faber, 1996; Smith and Pereda, 2003).
This potentiation is triggered by brief bursts of afferent
activity and requires the activation of NMDA receptors
and Ca2+/calmodulin-dependent kinase II (Pereda
et al., 1998).er Inc.
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Endocannabinoids Mediate Synaptic PotentiationBecause CB1Rs were also reported to be present in tel-
eost fish (Yamaguchi et al., 1996; McPartland et al., 2007),
including goldfish (Yazulla et al., 2000; Cottone et al.,
2005; Valenti et al., 2005), we asked whether endocanna-
binoids andCB1Rswere involved in promoting depression
at these synapses, an essential requirement for the
bidirectional control of the synaptic strength at these audi-
tory afferents. Unexpectedly, we found that dendritic
endocannabinoid release leads to potentiation of both
electrical and chemical transmission at Club endings.
This potentiating effect requires activation of CB1Rs and
is indirectly mediated by dopamine release from nearby
varicosities, which in turn leads to potentiation of the
synaptic response.
RESULTS
CB1 Receptor Activation Enhances Mixed
Synaptic Transmission
Electrical stimulation of the posterior branch of the VIIIth
nerve (where auditory afferents that terminate as Club
endings run) evokes a distinct excitatory synaptic poten-
tial (‘‘mixed EPSP’’; Figure 1A) composed of an early, brief
gap junction-mediated electrical component (represent-
ing the electrical coupling of the presynaptic action poten-
tials) and a delayed, longer-lasting glutamatergic re-
sponse. These two components of the synaptic potential
can be unambiguously identified and reliably measured
during intracellular dendritic recordings due to the brief
membrane time constant of the postsynaptic M cell, esti-
mated as 400 ms (Fukami et al., 1965). Endocannabi-
noids mediate their central regulatory actions via CB1Rs,
and their activation is expected to depress chemical syn-
aptic transmission (Chevaleyre et al., 2006). Thus, we
hypothesized that CB1R activation would lead to depres-
sion of the chemical component of the mixed EPSP. In-
stead, we found that bath application of WIN 55,212-2,
a CB1R agonist, led to a long-lasting enhancement of
both components (Figures 1B and 1C), averaging
136.4% ± 9.9%, p < 0.01, and 149.8% ± 13.0%, p <
0.01, of control values for the electrical and chemical com-
ponents, respectively (n = 8). The parallel changes in both
modalities of transmission cannot be ascribed to in-
creased input resistance of the M cell lateral dendrite, as
the amplitude of the antidromically evoked M cell spike
(a reliable estimate of this cell’s resistance due to the
lack of active electrogenesis in soma-dendritic mem-
brane) remained unchanged, averaging 102.6% ± 4.0%
of its control value (n = 8). In addition, the observed per-
cent increases for each synaptic component were consis-
tently different across experiments (ANOVA, F 54.85, F crit
3.93, p < 0.001), indicating that both forms of transmission
were, although simultaneously affected, differentially
modified by CB1R activation. The enhancements were
blocked by pretreatment with a combination of the CB1R
antagonists AM251 (AM; 4 mM) and SR141716 (SR; 4
mM), confirming that the observed effects were
mediated via CB1R activation (Figure 1D; electrical:Neuron106.2% ± 5.7%, p > 0.1; chemical: 111.7% ± 7.3%, p >
0.1; n = 8). As with previous studies in this preparation
(Pereda and Faber, 1996; Wolszon et al., 1997), we chose
to use a combination of blockers to overcome possible
differences in drug potency related to structural differ-
ences between the mammalian CB1R and its teleost or-
thologs, which share homology of 59% to 72% (Yamagu-
chi et al., 1996; McPartland et al., 2007). Also, application
of CB1R antagonists (Figure 1E) did not evoke changes in
the amplitude of either component of the mixed EPSP
(electrical: 98.4% ± 7.5%, p > 0.5; chemical: 110.0% ±
13.2%, p > 0.1; n = 8), indicating that endocannabinoids
are not tonically released in this system.
The effects of bath application of WIN could result from
activation of CB1Rs expressed on remotely located neu-
rons, so we asked whether local extracellular application
to the surrounding area of the M cell dendrite could evoke
similar enhancements of the synaptic response. For this
purpose, a second recording pipette with a solution
containing WIN was positioned in the vicinity of these ter-
minals in the distal portion of the lateral dendrite
(Figure 2A). Brief local application of WIN was sufficient
to trigger a long-lasting enhancement of the mixed EPSP
(Figure 2A; electrical: 146.5% ± 10.5%, p < 0.01; chemi-
cal: 148.0% ± 13.0%, p < 0.05; n = 6). These increases
did not result from continued activation of CB1Rs, a possi-
bility raised by the lipophilic nature of WIN, because they
were not modified by subsequent bath application of the
CB1R antagonists AM and SR (n = 3; data not shown).
Local WIN application suggested that endocannabi-
noids could mediate their actions via activation of CB1Rs
located in the proximity of these terminals. Immunohisto-
chemical studies with polyclonal antibodies raised against
either the first 14 (anti-CB1 1–14), the first 77 amino acids
(anti-CB1 1–77), or the carboxy terminus (anti-CB1-CT) of
the rat CB1R showed distinct punctate labeling near the
distal portion of the lateral dendrite (Figures 2 and 7A) in
the immediate vicinity of Club endings. This relationship
is illustrated in Figure 2B, where the position of Club end-
ings along the membrane of the M cell lateral dendrite is
revealed by an antibody against Cx35 (anti-Cx35/36). In-
terestingly, CB1-labeled puncta (anti-CB1 1–77), although
very close, do not appear to be on either the Club ending
or the M cell membranes (Figure 2C), a distribution more
clearly observed in side views of these terminals
(Figure 2D).
Dopamine Mediates WIN-Evoked Potentiation
The distribution of CB1-labeled puncta resembles the do-
paminergic varicosities that surround Club endings at the
distal portion of the M cell lateral dendrite (Figure 3A). Pre-
vious studies revealed that dopaminergic varicosities lie in
close proximity (within a few microns) to the M cell and
Club ending membranes and that brief local dopamine
application evokes long-lasting enhancements of both
components of the synaptic response (Pereda et al.,
1992). These enhancements require activation of dopa-
mine D1/5 receptors (D1/5Rs) that act via a postsynaptic56, 1034–1047, December 20, 2007 ª2007 Elsevier Inc. 1035
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Endocannabinoids Mediate Synaptic PotentiationFigure 1. Cannabinoids Evoke Long-Term Potentiation of Electrical and Chemical Transmission at Club Endings
(A) Experimental arrangement. Electrical stimulation of the posterior branch of the VIIIth nerve (VIIIth nerve), where Club endings (Club endings, Mixed
synapse) run, elicits a mixed excitatory postsynaptic potential (mixed EPSP).
(B) Bath application of WIN 55,212-2 (WIN; 500 nM) results in a long-term enhancement of both components of the synaptic response. (Top left)
Superimposed responses obtained 5 min before and 30 min after bath application of WIN (in all figures, traces represent the average of at least
ten responses). (Top right) The antidromic spike (AD spike) height (a measure of M cell input resistance) was slightly reduced. (Bottom) Time course
of both components of the VIIIth nerve synaptic response (each point is the average of ten single synaptic responses).
(C) Averaged time course of the electrical and chemical components of the mixed EPSP after bath application of WIN (500 nM; n = 8).
(D) Pretreatment with a combination of the CB1R antagonists AM251 and SR141716 (AM + SR; 4 mM each) blocked WIN-evoked potentiation (n = 8).
(E) Application of AM and SR had no effect on the amplitude of the electrical or chemical components of the mixed EPSP (n = 8).
Error bars represent the SEM.PKA phosphorylation pathway (Pereda et al., 1994). Thus,
we hypothesized that the synaptic enhancements evoked
by WIN application are mediated via dopamine release
from nearby varicosities. Pretreatment with the D1/5R
antagonist SCH-23390 (50 mM) prevented WIN-evoked
enhancements of the mixed EPSP (Figure 3B; electrical:
94.4% ± 7.4%, p > 0.1; chemical: 98.2% ± 10.4%, p >
0.5; n = 8). Consistent with this hypothesis, WIN-evoked
enhancements of the mixed EPSP were also blocked by
intracellular application of PKI 5-24 (PKI), a specific PKA
inhibitory peptide (Figure 3C; electrical: 89.4%, ± 6.6%,
p > 0.1; chemical: 88.4% ± 6.0%, p > 0.1; n = 5). Further-
more, the synaptic enhancement evoked by bath applica-1036 Neuron 56, 1034–1047, December 20, 2007 ª2007 Elsevition of WIN occluded the effects of locally applied dopa-
mine (Figure 3D; n = 3), suggesting that both forms of
potentiation share commonmechanisms. In contrast,WIN-
evoked enhancements did not occlude the long-term po-
tentiation triggered by stimulating the posterior VIIIth nerve
with brief (10ms) high-frequency (500Hz) trains (Figure 3D),
which is known to follow a different, Ca2+-dependent
intracellular signaling pathway (Pereda et al., 1998).
Endocannabinoids Are Released from the Lateral
Dendrite of the Mauthner Cell
Because endocannabinoids have limited diffusion proper-
ties, estimated to be 10–20 mm in rodent hippocampuser Inc.
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Endocannabinoids Mediate Synaptic PotentiationFigure 2. Brief Local Activation of CB1R Agonist Is Sufficient to Trigger Long-Term Potentiation of the Mixed EPSP
(A) (Top) Experimental arrangement for local drug application in the vicinity of Club ending contacts on the distal portion of the lateral dendrite and
labeling with anti-Cx35 antibodies. WIN (5 mM) was pressure ejected for 15 s. Traces represent the synaptic responses obtained 10min before and 30
min after local application. (Middle) Time course of both components of the mixed EPSP. (Bottom) Averaged time course of both components for six
experiments with local WIN application.
(B) Immunochemical analysis reveals the presence of CB1Rs in the vicinity of theMcell lateral dendrite. Laser scanning confocal immunofluorescence
in a double-immunolabeling experiment with anti-CB1 1–77 (red; Alexa Fluor 594), and anti-Cx35/36 (green, Alexa Fluor 488) antibodies. The image
reconstructs a long stretch of the lateral dendrite (average of three confocal Z-sections, totaling 1.5 mm) showing abundant presence of CB1Rs (red) in
the vicinity of the Club endings revealed by Cx35 labeling (green).
(C) Higher-magnification image of the area delimited by the dotted box in (B), illustrating the close proximity of CB1Rs to Club endings.
(D) Lateral view (average of three confocal Z-sections totaling 1.5 mm) shows labeling for CB1 in the immediate proximity of both the M cell dendrite
and a Club ending. The position of the M cell membrane (dotted lines) was estimated from the DIC image of the section.
Error bars represent the SEM.at 20C–22C (Wilson and Nicoll, 2001; Chevaleyre and
Castillo, 2003), we hypothesized that the source of their
productionmust lie in the vicinity of dopaminergic varicos-
ities. Furthermore, because the synthesis and release of
endocannabinoids usually takes place at postsynaptic
cells, often following activation of group I metabotropic
glutamate receptors (Maejima et al., 2001; Varma et al.,
2001; Ohno-Shosaku et al., 2001; Galante and Diana,
2004), we hypothesized that endocannabinoids are re-
leased from the M cell dendrite. Accordingly, immuno-
chemical analysis with confocal microscopy and an
mGluR1a antibody (anti-mGluR1) revealed strong labeling
at Club ending synapses (Figure 4A). Interestingly, labeling
was not restricted to the periphery of these mixed con-
tacts, where chemical synapses are located (Pereda
et al., 2003), suggesting the existence of an extrasynaptic
distribution of mGluR1 receptors (i.e., beyond the limits of
chemical synaptic domains but within the boundaries of
the contact; Figures 4B and 4C). Despite the presence
of mGluR1 receptors, local application of (RS)-3,5-dihy-Neurodroxyphenylglycine (DHPG; 1 mM), a group I mGluR
receptor agonist, did not result in an enhancement of the
mixed EPSP (Figure 4D; electrical: 90.8% ± 10.4%, p >
0.1; chemical: 87.8%± 11.1%, p > 0.1; n = 6). Endocanna-
binoids are also known to be released following postsyn-
aptic depolarizations (Ohno-Shosaku et al., 2001; Wilson
and Nicoll, 2001; Kreitzer and Regehr, 2001). However,
as with DHPG applications, strong dendritic depolariza-
tions (five pulses of 5 s duration and 90 nA of intensity) ex-
pected to bring the membrane potential to about 0 mV
(Experimental Procedures) did not elicit changes in the
amplitude of either component (Figure 4E; electrical:
108.0% ± 8.9%, p > 0.1; chemical: 92.9% ± 6.3%, p >
0.1; n = 6).
However, recent evidence shows that these manipula-
tions can cooperate for the release of endocannabinoids
(Ohno-Shosaku et al., 2002). We found that when local ap-
plication of DHPG was followed by dendritic depolariza-
tion, it successfully triggered lasting potentiations of the
mixed EPSP (Figure 4F; electrical: 151.1% ± 11.5%,n 56, 1034–1047, December 20, 2007 ª2007 Elsevier Inc. 1037
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Endocannabinoids Mediate Synaptic PotentiationFigure 3. Dopamine Mediates WIN-Evoked Potentiation of Synaptic Transmission at Club Endings
(A) Dopaminergic innervation of the M cell lateral dendrite (LD). Immunoreactive profiles obtained with an anti-dopamine antibody under Nomarski
optics reveal the presence of numerous varicose fibers (arrow) lying between the Club endings, which appear in cross section (asterisk).
(B) Averaged time course of both components of the mixed EPSP in eight experiments in which WIN (500 nM) application followed pretreatment with
the D1/5 antagonist SCH-23390 (50 mM).
(C) Averaged time course for five experiments in which the PKA inhibitor PKI (500 mM) was intradendritically injected prior to bath application of WIN.
(D) WIN-evoked potentiation occludes dopamine-evoked potentiation (10 mM). (Top) Mixed EPSPs obtained at control (control) and after each
experimental manipulation (WIN, Dopamine, TET) in one representative experiment. (Below) Time course of the amplitudes of the electrical and chem-
ical components of the mixed EPSP. Bath application of WIN triggers a long-lasting potentiation of the mixed EPSP that occludes the effects of local
dopamine application. In contrast, WIN-evoked potentiation did not occlude activity-dependent potentiation triggered by discontinuous high-fre-
quency stimulation of the VIIIth nerve (TET: burst of six pulses at 500 Hz, every 2 s over 4 min).
Error bars represent the SEM.p < 0.01; chemical: 148.1% ± 15.0%, p < 0.05; n = 6). This
protocol was more efficient (occurring in 100% of the
trials) when dendritic depolarizations were applied 10 min
after local application of DHPG (Figure 4F). This is likely
due to the diffusion time required for this agonist to reach
a significant number of the synaptic contacts, which are
distributed along an 250 mm length of the M cell lateral
dendrite. Consistent with this potentiation being mediated
by endocannabinoid release, the observed effects were
blocked by pretreatment with the CB1R antagonists AM
and SR (Figure 4G; electrical: 108.7% ± 4.6%, p > 0.1;
chemical: 105.6% ± 6.1%, p > 0.1; n = 6).
Given the properties of the mixed synaptic responses,
the combined requirement of mGluR activation and den-
dritic depolarization suggested that patterns of activity
of Club endings could be responsible for endocannabi-
noid release under natural conditions. Club endings repre-
sent the overwhelming majority of the excitatory inputs in1038 Neuron 56, 1034–1047, December 20, 2007 ª2007 Elsevithis portion of the M cell lateral dendrite, and the electrical
component of their mixed EPSP evokes a large dendritic
depolarization that is immediately followed by a glutama-
tergic response (the depolarization produced by the elec-
trical component is generally four to five times bigger than
that of the glutamatergic response; Figure 5A). Therefore,
we asked whether patterns of stimulation of the posterior
VIIIth nerve could trigger long-term enhancement of the
synaptic response. We found that repetitive activity at
100 Hz, a frequency known to promote endocannabinoid
release in other systems (Maejima et al., 2001; Chevaleyre
and Castillo, 2003; Galante and Diana, 2004; Brenowitz
and Regehr, 2005), evoked long-term potentiation of the
mixed EPSP (Figure 5B; electrical: 161.1% ± 14.0%, p <
0.05; chemical: 178.6% ± 18.2%, p < 0.05; n = 5;
antidromic spike was unchanged: 97.7% ± 8.0%). This
prolonged pattern of activity resembled the conditions
found for endocannabinoid release (Figure 4F) and waser Inc.
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Endocannabinoids Mediate Synaptic PotentiationFigure 4. Endocannabinoids Are Re-
leased from the Mauthner Cell Lateral
Dendrite
(A) Immunochemical analysis reveals the pres-
ence of mGluR1 at Club endings. Laser scan-
ning confocal immunofluorescence image
obtained with polyclonal anti-mGlur1 (green,
Alexa Fluor 488); average of 11 confocal Z-sec-
tions totaling 5.5 mm. Club endings (arrow-
heads), unambiguously identified because of
their larger size, exhibit punctate labeling for
mGluR1.
(B and C) Higher-magnification images show-
ing the distribution of mGluR1 at two Club end-
ings. Note that the labeling is not restricted to
the periphery of the contact, where chemical
synapses are localized.
(D–G) Both mGluR1 activation and dendritic
depolarization are required for endocannabi-
noid release. (D) Time course of the electrical
and chemical components of the mixed EPSP
in experiments with local application of the
mGluR I agonist DHPG (1 mM) in the vicinity
of the M cell dendrite (n = 6). (E) Time course
of experiments with dendritic depolarization of
the M cell (five pulses, 5 s duration each, 90 nA
of current, ‘‘depo’’; n = 6). (F) Combination of
local application of DHPG and dendritic depo-
larization triggered long-lasting enhancement
of the mixed EPSP (n = 6). (G) CB1R antago-
nists AM and SR prevented the potentiation
triggered by DHPG application and dendritic
depolarization (n = 6).
Error bars represent the SEM.radically different from that used for the induction of a dis-
tinct ‘‘long-term potentiation,’’ which required brief bursts
of 10 ms duration at 500 Hz over several minutes (Yang
et al., 1990). Furthermore, the potentiation triggered by
this stimulating paradigm involved endocannabinoid re-
lease, as the observed effects were blocked by pretreat-
ment with AM and SR (Figure 5C; electrical: 112.2% ±
17.7%, p > 0.5; chemical: 114.0% ± 16.3%, p > 0.1;
n = 5). Thus, our results indicate that endocannabinoids
are produced and released on demand from theM cell lat-
eral dendrite as a result of the activity of Club endings,
leading to long-term potentiation of both components of
the synaptic response via CB1R activation.
The endocannabinoid 2-arachidonoyl-glycerol (2-AG)
has been implicated in several forms of synaptic plasticity
in the mammalian nervous system (Chevaleyre et al.,
2006). Therefore, we askedwhether this endocannabinoid
was also responsible for the observed potentiations at
goldfish mixed synapses. To explore this possibility we
tested the effects of tetrahydrolipstatin (THL; 100 mM),
an inhibitor of diacylglycerol lipase (DGL), which converts
diacylglycerol into 2-AG, on the ability of the 100 Hz pat-
tern of stimulation to evoke long-term changes in the syn-
aptic strength. Intradendritic injections of THL preventedNeuropotentiation of the mixed EPSP (Figure 5D; electrical:
107.3% ± 6.6%, p > 0.1; chemical: 102.9% ± 7.0%, p >
0.5; n = 5).
Our data suggest that the CB1R mediates its effects via
dopamine release from nearby varicosities. To confirm
this, we tested the effects of pretreatment with the D1/5R
antagonist SCH-23390 (50 mM) on the ability of the
100 Hz stimulation protocol to evoke long-term changes
in the synaptic strength at these terminals. As illustrated
in Figure 5E, SCH-23390 prevented the potentiation of
the mixed EPSP (electrical: 92.3% ± 3.7%, p > 0.1; chem-
ical: 92.3% ± 4.3%, p > 0.1; n = 5). Thus, activity-depen-
dent production of the endocannabinoid 2-AG at the M
cell lateral dendrite is sufficient to trigger local dopamine
release, which in turn evokes a long-term potentiation of
the mixed synaptic response.
CB1 Receptors Are Closely Associated
With Dopaminergic Varicosities
Endocannabinoids are expected to suppress transmitter
release by acting on presynaptic CB1Rs. In contrast, our
data strongly suggest that activation of these receptors
leads to increased dopamine release. A mechanism com-
patible with the well-established conventional presynapticn 56, 1034–1047, December 20, 2007 ª2007 Elsevier Inc. 1039
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Endocannabinoids Mediate Synaptic PotentiationFigure 5. Endocannabinoid Release Is
Triggered by Synaptic Activity
(A) Repetitive stimulation (100 Hz) of the poste-
rior VIIIth nerve provides both strong depolar-
ization via gap junctions and glutamate
release.
(B) Repetitive stimulation of the posterior VIIIth
nerve (100 Hz during 1 s 3 5) evoked robust
potentiation of both components of the mixed
EPSP (n = 5).
(C) Pretreatment with CB1R antagonists AM
and SR (4 mM) blocked synaptic potentiation
(n = 5).
(D) Intradendritic injections of THL (100 mM),
a diacylglycerol lipase (DGL) inhibitor, pre-
vented synaptic potentiation (n = 5).
(E) Dopamine D1/5R activation is required for
synaptic potentiation triggered by repetitive
stimulation. Pretreatment with the D1/5 antago-
nist SCH-23390 (50 mM) blocked synaptic
potentiation (n = 5).
Error bars represent the SEM.effects of endocannabinoids would be that dopamine
release is enhanced as a result of suppression of GABA re-
lease from nearby inhibitory terminals. This phenomenon,
known as ‘‘disinhibition,’’ is proposed to occur at soma of
dopaminergic neurons in the ventral tegmental area of the
rat (Szabo et al., 2002) and substantia nigra of the mouse
(Wallmichrath and Szabo, 2002). Supporting this possibil-
ity, Club endings and dopaminergic varicosities are
closely surrounded in the long and smooth (spineless) lat-
eral dendrite of the M cell by a large number of inhibitory
terminals (‘‘small vesicle boutons’’) (Tuttle et al., 1987),
which are predominantly GABAergic (Triller et al., 1993).
As in other systems, CB1Rs could act presynaptically on
these terminals to inhibit release (Freund et al., 2003).
Given the presence of numerous inhibitory terminals in
the lateral dendrite, spillover of GABA could act to influ-
ence transmitter release from nearby dopaminergic vari-
cosities. Indeed, spillover of transmitter has been shown
to occur between inhibitory synapses on the M cell (Faber
and Korn, 1988). Experimentally, these terminals can be
activated by antidromically stimulating the M cell axon,
as they participate in a feedback inhibitory circuit (Fig-
ure 6A). Since the equilibrium potential of chloride (Cl)
in the M cell lies close to its resting potential, visualization
of the feedback inhibitory synaptic potential requires intra-
cellular Cl loading (Figure 6B), often difficult to maintain
at constant levels. A more accurate assay for the strength
of these inhibitory connections is to measure the change
in membrane conductance (‘‘shunt’’) produced by the
opening of ligand-gated Cl channels. The conductance1040 Neuron 56, 1034–1047, December 20, 2007 ª2007 Elsevichange (‘‘fractional conductance’’) is proportional to the
ratio between the amplitude of the M cell antidromic spike
in the absence and presence of the inhibitory synaptic
potential (Oda et al., 1995). For this purpose, a second an-
tidromic stimulating pulse was applied 6 ms after the first,
conditioning pulse (Figure 6C). We asked whether this
ratio could be affected by local application of WIN or den-
dritic release of endocannabinoids (DHPG + depolariza-
tion) and found that neither manipulation led to changes
in fractional conductance, averaging 105.8% ± 9.3%,
p > 0.5, and 100.5% ± 7.6%, p > 0.9, respectively (n = 6).
The absence of effect on dendritic inhibition did not
result from the inability to detect changes in synaptic inhi-
bition, as this ratio was increased after bath application of
WIN (199.4%±34.7%, p< 0.05), indicating an unexpected
enhancement of feedback inhibitory transmission. Be-
cause dendritic applications did not induce changes in
the inhibitory synaptic response, we concluded that the
observed enhancement must result from changes in feed-
back inhibitory neurons innervating the M cell soma (lo-
cated 500 mm from the dendritic injection site), which
are predominantly glycinergic (Figure 6A) (Triller et al.,
1993). Remarkably, this effect was not observed in the
presence of CB1R antagonists (AM-SR), the D1/5R antago-
nist SCH-23390, or following intracellular injections of PKI;
fractional conductance averaged 99.2% ± 6.4% (p > 0.5),
n = 8; 100.2% ± 6.2% (p > 0.5), n = 8, and 80.0% ± 7.9%
(p > 0.05), n = 5, respectively (Figure 6D), suggesting that
the observed enhancement of synaptic inhibition was
also mediated by dopamine release via a postsynapticer Inc.
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Endocannabinoids Mediate Synaptic PotentiationFigure 6. Inhibitory Synaptic Transmis-
sion to the M Cell in the Vicinity of Club
Endings Is Not Modified by CB1R Activa-
tion
(A) Experimental arrangement. The cartoon
illustrates the relative distribution of inhibitory
interneurons on the M cell soma (mostly glyci-
nergic) and lateral dendrite (mostly GABAer-
gic), which are recurrently activated by anti-
dromic stimulation (AD).
(B) Cl loading of the M cell reveals the pres-
ence of a powerful recurrent inhibitory synaptic
potential in response to antidromic stimulation
(AD spike).
(C) The strength of the feedback inhibition was
quantified by determining the fractional con-
ductance (expressedaspercentageof control).
(D) Neither local application of WIN (Local WIN)
nor local release of endocannabinoids trig-
gered by DHPG and dendritic depolarization
(DHPG + Depo) affected the strength of recur-
rent inhibition. In contrast, bath application of
WIN (Bath WIN) led to a marked increase in
recurrent inhibition, suggesting that inhibitory
synapses in the soma are sensitive to endo-
cannabinoid modulation. This enhancement
was prevented by application of CB1R antago-
nists AM and SR, the dopamine D1/5R antago-
nist SCH-23390, and the PKA blocker PKI.
(E) Bath application of the GABAA receptor
antagonist bicuculline (75 mM) prior to repeti-
tive stimulation (100 Hz) of the posterior VIIIth
nerve does not prevent the induction of activ-
ity-dependent synaptic potentiation. (Bottom
left) Time course of the mixed EPSP from a single experiment during baseline recordings following repetitive stimulation of the posterior VIIIth nerve
(gray bar). Note the lack of modification in baseline following the application of bicuculline and prior to repetitive stimulation. (Top) Responses to
antidromic stimulation of the M cell axon obtained at the time points 1 (13 min), 2 (4 min), and 3 (40 min) indicated in the graph. Bicuculline
led to a suppression of recurrent inhibition at time points 2 and 3, indicated by the increase in the amplitude of the second antidromic action potential
(bars at the second antidromic spikes in 2 and 3 indicate the amplitude prior to drug application). (Bottom right) Averaged time course of five exper-
iments in which pretreatment with bicuculline did not prevent the potentiation triggered by repetitive stimulation at 100 Hz.
Error bars represent the SEM.mechanism. In agreement, immunochemical analysis
showed thatbothdopaminergicfibersandCB1Rsweredis-
tributed in the vicinity of the M cell soma (data not shown).
The lack of effect of cannabinoids on dendritic inhibi-
tion, largely GABAergic (Triller et al., 1993), suggests
that disinhibition mechanisms are unlikely to underlie
dopamine release from nearby varicosities. To directly de-
termine whether disinhibition is involved in promoting the
dopamine release, we studied the effect of the GABAA an-
tagonist bicuculline on both the amplitude of the mixed
EPSP and the ability of repetitive stimulation of the VIIIth
nerve at 100Hz to trigger potentiation. If dopamine release
results from a reduction of GABA inhibitory influences, the
addition of bicuculline is expected to induce an enhance-
ment of the mixed EPSP. In contrast, we found that bath
application of bicuculline did not lead to changes in the
baseline amplitude of either component of the mixed
EPSP (Figure 6E, bottom left). Furthermore, pretreatment
with bicuculline did not prevent activity-dependent poten-
tiation of the electrical and chemical components of the
synaptic response evoked by repetitive stimulation ofNeuronthe VIIIth nerve at 100 Hz (148.9% ± 16.6%, p < 0.5, and
156.4% ± 19.4%, p < 0.5, respectively; n = 5; Figure 6E,
bottom right). In contrast, bicuculline abolished recurrent
inhibition (Figure 6E, top).
Thus, our results indicate that disinhibition of dopami-
nergic varicosities near the lateral dendrite does not con-
stitute the mechanism underlying dopamine release.
However, recent evidence demonstrates that CB1Rs are
presynaptically distributed in the axons and varicosities
of other aminergic neurons (Oropeza et al., 2006), sug-
gesting that their activation could be responsible for the
release of noradrenaline (Oropeza et al., 2005). Therefore,
we investigated the colocalization of CB1Rs and dopami-
nergic varicosities in the M cell lateral dendrite via double
immunolabeling with anti-CB1-CT and anti-tyrosine hy-
droxylase (anti-TH) antibodies (Figure 7A). We found close
association and overlap of CB1-labeled puncta and TH-
labeled dopaminergic fibers and varicosities in a pattern
consistent with localization of these receptors on dopami-
nergic varicosities or processes immediately adjacent to
them (Figure 7B). The observed distribution suggests56, 1034–1047, December 20, 2007 ª2007 Elsevier Inc. 1041
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mine release via unconventional presynaptic mecha-
nisms. As illustrated in Figure 7A, most of the CB1-labeled
puncta were not associated with TH-labeled fibers, indi-
cating a wide distribution of this ubiquitous receptor in
other cell types of the goldfish hindbrain. Nevertheless,
the incidence of the association between CB1 and dopa-
minergic varicosities was certainly underestimated, as
anti-TH immunofluorescence proved to have a lower effi-
ciency (20%) in detecting these fibers when compared
with that of anti-dopamine antibodies combined with per-
oxidase methods (Figure 3A; also Pereda et al., 1992).
Cx35 Is a Direct Target of PKA Phosphorylation
at Club Endings
Cx35 contains several PKA phosphorylation sites, and
PKA can directly phosphorylate Cx35 to modify its func-
tion (Mitropoulou and Bruzzone, 2003; Ouyang et al.,
2005; Urschel et al., 2006). We asked whether Cx35 could
be similarly phosphorylated at Club endings. For this pur-
pose, western blots were obtained from small areas of the
goldfish hindbrain containing the M cells with a polyclonal
antibody raised against a PKA phosphorylation site at ser-
ine 110 of Cx35 (anti-Cx35/P110). This antibody labeled
Cx35 (two closely spaced bands at 32–33 kDa), and label-
ing was lost upon alkaline phosphatase digestion, sug-
gesting that this connexin is also the target of PKA phos-
phorylation in neurons of this region that includes the M
cells (Figure 8A). Accordingly, immunohistochemical stud-
ies using the anti-Cx35/P110 antibody revealed abundant
punctate labeling at Club endings, which were unambigu-
ously identified by the presence of labeling with themono-
clonal anti-Cx35/36 antibody (Figures 8B and 8C).
DISCUSSION
Contrasting with their well-defined role in promoting
depression of synaptic transmission, our results show
that endocannabinoids evoked long-term enhancement
of synaptic transmission at mixed contacts between
Club endings and the M cell lateral dendrite. As previously
demonstrated in other cell types, endocannabinoids are
released from the postsynaptic dendrite (Freund et al.,
2003); in this case, release requires simultaneous mGluR1
activation and postsynaptic depolarization. Such require-
ments are ideally suited to the characteristics of the syn-
aptic potential evoked by Club endings, where glutamate
release is always accompanied by the large dendritic
depolarization produced by the spread of the presynaptic
action potentials via the numerous gap junctions present
at these terminals. Accordingly, we show that activity of
these afferents leads to endocannabinoid release and
subsequent potentiation of synaptic transmission, sug-
gesting that this signaling system is likely to participate
in the regulation of the synaptic strength of these afferents
under natural conditions. Club endings provide the M cell
with essential auditory information for the initiation of an
escape response (Korn and Faber, 2005). Activity-1042 Neuron 56, 1034–1047, December 20, 2007 ª2007 Elsevdependent release of endocannabinoids may have an
important functional role, as the increased synaptic gain
of these VIIIth nerve synapses will sensitize this vital
behavior, lowering its threshold to auditory stimuli.
The enhancements in transmission observed following
endocannabinoid release and CB1R activation cannot be
ascribed to possible interactions with other well-known
potentiating mechanisms present at Club endings (Yang
et al., 1990), as those do not require PKA activation
(Kumar and Faber, 1999; Pereda et al., 1998). Further-
more, the stimulation pattern used to trigger the observed
endocannabinoid-mediated potentiation was radically dif-
ferent from that used for the induction of the previously
described ‘‘long-term potentiation’’ of both components
of the mixed synaptic response (Yang et al., 1990). In con-
trast to that used to trigger endocannabinoid release, this
protocol consists of brief (10 ms) high-frequency (500 Hz)
trains of stimuli applied every 2 s during 4 min, a pattern
known to optimize activation of NMDA receptors that are
required for the induction of these synaptic changes
(Yang et al., 1990; Pereda and Faber, 1996). This potenti-
ation requires an intracellular increase in Ca2+ that in turn
leads to the activation of Ca2+/calmodulin-dependent
Figure 7. CB1Rs Are Closely Associated to Dopaminergic
Fibers
(A) Laser scanning confocal immunofluorescence with double immu-
nolabeling by polyclonal anti-CB1-CT (red, Alexa Fluor 594) and
monoclonal anti-TH (green; Alexa Fluor 488) antibodies. Image is the
average of 31 confocal Z-sections (totaling 6.2 mm).
(B) Magnification of the boxed area from (A) illustrates close associa-
tion between CB1Rs and dopaminergic fibers, compatible with presyn-
aptic localization of CB1Rs on the membrane of the varicosities (image
is the average of nine Z-sections, totaling 1.8 mm).ier Inc.
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(A) Polyclonal anti-Cx35/P110 antibody recognizes Cx35 as a pair of
bands at 32–33 kDa (arrow, left lane, AP-) in membranes from a small
area of goldfish hindbrain where M cells are located. Labeling is lost in
membranes digested with alkaline phosphatase (right lane, AP+). The
highmolecular weight phospho-proteins labeled nonspecifically by the
antibody are not associated with Cx35 (Kothmann et al., 2007). 50 mg/
lane crude membrane protein.
(B) Laser scanning confocal immunofluorescence of a single Club end-
ing with double labeling by polyclonal anti-Cx35/P110 (green, Alexa
Fluor 488) and monoclonal anti-Cx35/36 (mCx35; red, Alexa Fluor
594) antibodies. (Top) Superimposition of individual mCx35 and
Cx35-P images (bottom), average of three confocal Z-sections (total-
ing 1.5 mm).
(C) Lower-magnification image showing extensive colocalization at
individual Club endings in a section of the M cell lateral dendrite. A
DIC image of this region is superimposed.
(D) Model for endocannabinoid-mediated potentiation of electrical and
chemical synaptic transmission at Club endings. Synaptic activityNeuronkinase II (Pereda et al., 1998) and was not prevented by in-
tracellular injection of PKA inhibitors or bath application of
dopamine D1/5R antagonists (Kumar and Faber, 1999).
Thus, our results suggest that several activity-dependent
mechanisms might converge for the regulation of the
synaptic strength at these auditory afferents.
Endocannabinoids Regulate the Strength
of Electrical Synapses
Our data demonstrate that electrical synapses, whose
functional roles in themammalian CNS have been increas-
ingly recognized (Connors and Long, 2004), are the target
of endocannabinoid control. Most of the known effects of
cannabinoids on gap junctional communication are so far
restricted to nonneural tissue (Brandes et al., 2002; Up-
ham et al., 2002). In the nervous system, the endogenous
cannabinoid anandamide was reported to decrease junc-
tional conductance between cultured astrocytes, al-
though this effect was not mediated via activation of
CB1Rs (Venance et al., 1995). Given that electrical trans-
mission at these terminals is mediated by Cx35 (Pereda
et al., 2003), the fish ortholog of the widespread neuron-
specific Cx36 (O’Brien et al., 1998; Condorelli et al.,
1998), our results suggest that mammalian electrical syn-
apses could be similarly regulated. Endocannabinoids, in
particular 2-AG, have a well-established role in modulat-
ing chemical synaptic transmission (Alger, 2002; Freund
et al., 2003; Chevaleyre et al., 2006). The present results
show that their modulatory role is not restricted to a spe-
cific modality of synaptic transmission, and they suggest
a general role for the endocannabinoid system in shaping
interneuronal communication in general.
CB1R-evoked dopamine release potentiated both
forms of transmission via postsynaptic activation of
PKA. Ionotropic glutamate receptors are known to be tar-
gets of PKAmodulatory action in a variety of experimental
preparations where PKA phosphorylation mediates
changes of synaptic transmission (Swope et al., 1999).
Both Cx35 and its mammalian ortholog Cx36 have also
been shown to be targets of PKA phosphorylation (Mitro-
poulou and Bruzzone, 2003; Ouyang et al., 2005; Urschel
et al., 2006). We show here that Cx35 is phosphorylated at
regulatory PKA phosphorylation sites in Club endings.
Thus, endocannabinoid release is likely to potentiate elec-
trical transmission via a direct action on this connexin.
Synaptic Potentiation Is Mediated
via the Release of Dopamine
The effects of cannabinoids required bothCB1 andD1/5 re-
ceptor activation, indicating that potentiation is mediated
leads to mGluR activation paired with postsynaptic membrane depo-
larization, triggering endocannabinoid (eCB) release from the postsyn-
aptic M cell dendrite, which activates CB1Rs on dopaminergic fibers.
CB1R activation leads to dopamine release that, by activating postsyn-
aptic D1/5 receptors, increases PKA activity responsible for simulta-
neous potentiation of electrical (Cx35) and glutamatergic (GluR)
synaptic transmission.56, 1034–1047, December 20, 2007 ª2007 Elsevier Inc. 1043
Neuron
Endocannabinoids Mediate Synaptic Potentiationindirectly via dopamine release. We previously showed
the presence of a rich dopaminergic innervation in the
vicinity of the M cell lateral dendrite and demonstrated
that local dopamine application is sufficient to trigger
a lasting potentiation of both components of the
synaptic response (Pereda et al., 1992). We show now
that dopamine release is under the regulatory control of
local factors such as dendritic endocannabinoid produc-
tion. Thus, by the action of neurotransmitter modulators,
endocannabinoids can amplify and promote regulatory
actions that go beyond their conventional effects on
synaptic transmission. Furthermore, because endocanna-
binoids are thought to travel no more than 10–20 mm,
dopamine release could also act to spatially amplify their
regulatory effects, as this less lipophilic neurotransmitter
would diffuse a greater distance along the dendritic tree.
We found a close association of CB1Rswith dopaminer-
gic varicosities, suggesting their localization on these ter-
minals.While this possibility is consistentwith the classical
distribution of these receptors on presynaptic terminals, it
is in contradiction with the conventional suppressive ef-
fects of CB1Rs on synaptic transmission (Freund et al.,
2003), as activation of these receptors would lead instead
to increased dopamine release. Recently, similar presyn-
aptic distribution of CB1Rs was reported in the axons
and varicosities of othermonoaminergic neurons (Oropeza
et al., 2006), where they have been proposed to promote
release of noradrenaline (Oropeza et al., 2005). Taken to-
gether, these findings raise the possibility that CB1Rs lo-
cated on monoaminergic varicosities could be coupled
to alternative signaling pathways, making them capable
of enhancing transmitter release. Consistent with this pos-
sibility, recent evidence shows that CB1Rs are not exclu-
sively coupled to Gi/o (which is in turn negatively coupled
to adenylate cyclase) but also to Gq/11 (Lauckner et al.,
2005) and Gs (Glass and Felder, 1997), suggesting that
intracellular signaling triggered by activation of these re-
ceptors could be more diverse than originally anticipated.
Supporting these observations, studies in slices of globus
pallidus (Maneuf andBrotchie, 1997), cultured striatal neu-
rons (Glass and Felder, 1997; Jarrahian et al., 2004), and
chinese hamster ovary cells (Bonhaus et al., 1998) re-
ported that CB1R activation can lead to increases in the in-
tracellular concentration of cAMP. Furthermore, activation
of CB1Rs in neuroblastoma cells was shown to promote an
increase in cytoplasmic Ca2+ levels through a pathway in-
volving both Gs and PKA (Rubovitch et al., 2002; Bash
et al., 2003). Thus, the ability of these receptors to promote
increases in cAMP and intracellular Ca2+ opens the possi-
bility that similar mechanisms could underlie enhanced
transmitter release fromdopaminergic varicosities. Finally,
CB1Rscould enhancedopamine releasebymodifyingpre-
synaptic excitability and/or the properties of presynaptic
action potentials, as these receptors have been shown to
target K+ currents in goldfish retinal bipolar cells (Fan and
Yazulla, 2005).
An alternative possibility that we considered was that
CB1Rs located on nearby inhibitory terminals or pro-1044 Neuron 56, 1034–1047, December 20, 2007 ª2007 Elsevicesses that are presynaptic to dopaminergic varicosities
act to regulate GABA release. This mechanism seems
highly unlikely given the lack of effect on dendritic inhibi-
tion and the absence of direct contacts with either the M
cell or presynaptic terminals in serial EM reconstructions
of dopaminergic varicosities (Pereda et al., 1992). This
possibility was directly ruled out in experiments where
activity-dependent potentiation was observed in the pres-
ence of blockers of GABAergic transmission, indicating
that inhibition is not required for the induction or expres-
sion of this potentiation. Thus, our results indicate that
dopamine release is not mediated by ‘‘disinhibition’’ of
dopaminergic varicosities, and therefore, activation of
the CB1R must necessarily increase dopamine release
directly.
Enhancement of Inhibitory Synaptic Transmission
Interestingly, our results show that while inhibitory synap-
ses on the M cell lateral dendrite are insensitive to CB1R
activation, those targeting the soma were enhanced by
CB1R activation. This finding represents a novel endocan-
nabinoid regulatory action, as inhibitory transmission in
hippocampus and neocortex is consistently reported to
be depressed by CB1R activation (Freund et al., 2003;
Chevaleyre et al., 2006). Because inhibitory synapses on
the soma are predominantly glycinergic (Triller et al.,
1993), the results suggest the existence of a differential
sensitivity of the predominantly GABAergic dendritic in-
hibitory synapses to endocannabinoid modulation. Our
results show that this enhancement of somatic inhibition
is also mediated by dopamine and a PKA-dependent
postsynaptic mechanism. Consistent with these findings,
intracellular injections of cAMP or aminophylline (that in-
hibits phosphodiesterase and therefore cAMP degrada-
tion) in theM cell soma have been shown to enhance feed-
back inhibition (Wolszon and Faber, 1989). Because
dendritic release of endocannabinoids did not affect feed-
back inhibition (consistent with limited diffusion of these
lipidic messengers), a second source of endocannabinoid
release seems to be required to modify inhibitory synaptic
transmission at the soma. Thus, our findings suggest that
neurons could be endowedwithmultiple sites of endocan-
nabinoid production to modulate the strength of synaptic
inputs at specific cellular compartments.
Endocannabinoids and Dopamine Function
Behavioral, biochemical, and electrophysiological data
have increasingly implicated the involvement of dopamine
in the central actions of cannabinoid compounds (Van der
Stelt and Di Marzo, 2003). However, the sites and cellular
mechanisms by which cannabinoids and dopamine sys-
tems interact remain to be determined. We describe
here a novel form of interaction between these two sys-
tems in which dendritic endocannabinoid production is
capable of inducing local release of dopamine from
nearby varicosities. Localized interactions between can-
nabinoid and dopaminergic systems could constitute
a more general property relevant to structures whereer Inc.
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as basal ganglia (Marsicano and Lutz, 1999; Hohmann
and Herkenham, 2000) and prefrontal cortex (Herkenham
et al., 1990), and contribute to the motor and addictive ef-
fects of the marijuana products. These interactions might
also be relevant to the retina, which contains dopamine
receptors, abundant gap junctions, and CB1Rs (Fan and
Yazulla, 2005).
EXPERIMENTAL PROCEDURES
Electrophysiology
Intracellular in vivo recordings from adult goldfish (Carassius auratus)
were performed as previously described (Pereda et al., 1994). Briefly,
responses to VIIIth nerve or spinal cord stimulation were recorded
from the lateral dendrite of theMcell (300–400mmfrom the axonhillock)
with glassmicroelectrodes (4–7MU) containing 5MK-Acetate, pH 7.2.
Due to the brief membrane time constant of the M cell (400 ms), both
components of the synaptic potential can be unambiguously identified
and reliablymeasured, as the brief duration of the electrical component
doesnot significantly influence thepeakof thesubsequent chemical re-
sponse (peak amplitudes were detected within a range of points using
Igor software). Synaptic potentials were monitored every 4 s, and
traces were averaged in sets of ten or more. Amplitude changes were
estimatedbycomparing averagesobtained at baseline and30minafter
each experimental manipulation. Results are expressed as mean ±
SEM. Student’s t test was used to assess statistical significance of
the data, unless otherwise stated (level of significance: 5%). The ampli-
tude of the M cell antidromic action potential was routinely monitored
and taken as an indicator of the cells’ input resistance. The strength
of the feedback inhibition was quantified by measuring amplitude
changes in a second antidromic action potential (6 ms interval) super-
imposed on the inhibitory response (the reduction in amplitude of the
second action potential is proportional to the membrane shunting pro-
duced by the opening of ligand-gated Cl channels) and expressed as
the ratiobetween the amplitudesof the first, conditioning, action poten-
tial (V) and the second, or ‘‘test,’’ action potential. This ratio, ‘‘fractional
conductance,’’ was defined as (V/V0)  1 (Oda et al., 1995). In order to
activate the auditory afferents, a bipolar stimulating electrode (FHC,
Brunswick, ME) was placed on the posterior VIIIth nerve. To obtain
‘‘long-term potentiation’’ of the mixed EPSP, high-frequency stimula-
tion of the posterior VIIIth nerve, consisting of six pulses at 500 Hz
applied every 2 s, was applied over 4 min (‘‘TET’’ in Figure 3D). In the
case of dendritic depolarizations, the protocol consisted of a total of
five pulses of 90 nA, 5 s duration each, applied every 4 s through the
recording electrode; this amount of current is expected to bring the
membrane potential to approximately 0mV (estimated input resistance
1 MU) (Pereda et al., 1992; Wolszon et al., 1997).
Drug Application
WIN 55,212-2 (500 nM; Tocris), SR141716 (4 mM; NIMH Drug Supply
program), AM251 (4 mM; Tocris), SCH-23390 (50 mM; Biomol), and
bicuculline methiodide (75 mM; Sigma) were bath-applied by superfu-
sion of the brain after dilution in artificial CSF. WIN 55,212-2,
SR141716, AM251, and tetrahydrolipstatin (THL) were prepared from
5mMstocks in DMSO. For extracellular local application, a secondmi-
croelectrode (12–16 MU) was positioned 300–400 mm from the axon
hillock and 20–30 mm above the M cell lateral dendrite. WIN (5 mM),
(RS)-3,5-dihydroxyphenylglycine (DHPG; 1 mM; Tocris) or dopamine
(10 mM; Calbiochem) were dissolved in 130 mM NaCl and 10 mM
HEPES, pH 7.2, and pressure-ejected (Picospritzer II, Parker Instru-
mentation, Cleveland, OH; five pulses of 3 s duration each, 20 psi). Ex-
tracellular application of this vehicle solution has been used in previous
studies (Pereda et al., 1992, 1994; Kumar and Faber, 1999) and does
not produce changes in recorded synaptic potentials. Ejection fromNeuronthe tip of the microelectrode was routinely verified at the end of each
experiment. In the case of intracellular injections, microelectrodes
(4–6 MU) contained the PKA inhibitor 5-24 (500 mM; Calbiochem) or
the DGL inhibitor THL (100 mM; Sigma) in 0.5MKCl and 10mMHEPES,
pH 7.2. This vehicle solution does not interfere with the induction of
plastic changes (Pereda et al., 1998; Kumar and Faber, 1999).
Immunohistochemistry
Fish were perfused intracardially with 4%paraformaldehyde. The brain
was removed and kept overnight in 4% paraformaldehyde, 30%
sucrose phosphate buffer and sectioned with a cryostat (18–50 mm).
The primary antibodies were as follows: monoclonal anti-connexin
35 (1:250; ‘‘anti-Cx35/36,’’ MAB3045, Chemicon); polyclonal anti-
connexin 35 phosphorylated at serine 110 (1:1000, ‘‘anti-Cx35/
P110,’’ John O’Brien) (Kothmann et al., 2007); polyclonal anti-
mGluR1a (1:200; ‘‘anti-mGluR1,’’ B1551, Chemicon); monoclonal
anti-tyrosine hydroxylase (1:500; ‘‘anti-TH,’’ MAB318, Chemicon);
polyclonal anti-CB1 carboxy terminus (1:750; ‘‘anti-CB1-CT,’’ Ken
Mackie) (Hajos et al., 2000); polyclonal anti-CB1 residues 1–77
(1:100; ‘‘anti-CB1 1–77,’’ ab3559, Novus) (Cottone et al., 2005; Valenti
et al., 2005), and polyclonal anti-CB1 residues 1–14 (1:100; ‘‘anti-CB1
1–14,’’ 101500, Cayman) (McIntosh et al., 1998; Yazulla et al., 2000).
Primary antibodies were detected using Alexa Fluor 594 (Molecular
Probes A11005) and/or Alexa Fluor 488 (Molecular Probes A11001).
Control sections were obtained in the absence of primary antibodies.
The sections were examined using a confocal microscope (Olympus
Fluoview 500) and analyzed using ImageJ (NIH) and Adobe Photoshop
software. The presence of dopamine was revealed with a polyclonal
anti-dopamine antibody (Geffard, Bordeaux, France) and an immuno-
peroxidase reaction using a secondary biotinylated anti-rabbit and
avidin-biotin-HRP complex (ABC Vectastain Kit, Vector, USA).
Immunoblotting
For western blots, crude goldfish plasma membranes were prepared
by differential centrifugation of fresh tissue homogenates from small
portions of goldfish hindbrain containing the M cells (Pereda et al.,
2003). Tissues were homogenized by sonication in ice-cold 0.32 M
sucrose, 10 mM Tris-Cl, pH 7.2, 2 mM EGTA, 5 mM MgCl2, 1% phos-
phatase inhibitor cocktail (Sigma), 1% protease inhibitor cocktail for
His-tagged proteins (Sigma). The suspension was centrifuged for
5 min at 1000 3 g to remove large particulates, and the supernatant
was centrifuged for 1 hr at 100,000 3 g to pellet membranes. The
membrane pellet was resuspended in the homogenization medium
without protease or phosphatase inhibitors plus 0.5% Igepal CA-
630. Protein concentration was measured by the BCA assay (Pierce).
For eachmembrane preparation, a portion was digested with bacte-
rial alkaline phosphatase. The membrane preparations were diluted to
4 mg protein/ml with alkaline phosphatase assay buffer (final com-
position: 10 mM Tris-Cl, 10 mM MgCl2, 0.5% Igepal CA-630, 30%
membrane homogenization buffer) and digested with 25 units alkaline
phosphatase (Fermentas, Hanover, MD) per mg protein for 2 hr
at 50C. The samples were then diluted to 2 mg protein/ml with
23 SDS sample buffer. Comparable nondigested samples were
prepared at the same concentration with alkaline phosphatase buffer
but no enzyme.
For Cx35 immunoblots, 50 mg aliquots of membrane protein were
dissolved in reducing SDS sample buffer and resolved on 12% gels.
Proteins were transferred at 18 V overnight to polyvinylidenedifluoride
membranes. Blots were blocked with 5% nonfat dry milk in TBST
(137 mM NaCl, 3 mM KCl, 25 mM Tris-Cl, pH 7.4, 0.1% Tween-20)
for 1 hr at room temperature. Blots were incubated with affinity-
purified phospho-Ser110-specific antibodies (‘‘anti-Cx35/P110,’’
John O’Brien) (Kothmann et al., 2007) diluted to 0.8 mg/ml in high-
salt TBST (500 mM NaCl, 3 mM KCl, 25 mM Tris-Cl, pH 7.4, 0.1%
Tween-20) plus 2% nonfat dry milk. Blots were also probed with
a monoclonal anti-Cx35/36 antibody (MAB3045, Chemicon) at
1 mg/ml under the same conditions. Blots were developed with56, 1034–1047, December 20, 2007 ª2007 Elsevier Inc. 1045
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Endocannabinoids Mediate Synaptic Potentiationperoxidase-linked secondary antibodies (Pierce) and detected by
chemiluminescence.
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